PinnyPeptide

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) vs Wolverine Blend (BPC-157 + TB-500)

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu)

Peptide Blends

Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial.

Peptide B

Wolverine Blend (BPC-157 + TB-500)

Peptide Blends

The classic recovery stack — BPC-157 paired with TB-500 for accelerated tissue repair.

Typical vial

80 mg

Typical dose

500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg

Half-life

KPV ~minutes; BPC-157 ~4 h; TB-500 ~6-8 h; GHK-Cu ~minutes systemically

FDA status

No component FDA approved for human use. FDA issued a warnin…

Typical vial

20 mg

Typical dose

250 + 2000 (BPC + TB) mcg

Half-life

BPC-157 ~4 h; TB-500 ~6-8 h

FDA status

Neither component is FDA approved for human use. FDA issued …

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) effects

  • Broad anti-inflammatory action across NF-κB, nitric oxide, and copper-modulation pathways
  • Soft-tissue healing and tendon recovery (BPC + TB contribution)
  • Stimulates collagen synthesis and skin elasticity (GHK-Cu contribution)
  • Anti-inflammatory action in the gut and inflamed skin (KPV contribution)
  • Modulates the gut-skin axis (anecdotal, component-derived)
  • Reduces scar formation and supports remodelling
  • Promotes angiogenesis and improved blood flow to repair sites

Wolverine Blend (BPC-157 + TB-500) effects

  • Accelerated tendon, ligament, and muscle recovery (component-derived)
  • Promotes angiogenesis and vascular repair
  • Upregulates actin and supports cell migration to injury sites
  • Modulates inflammation through nitric oxide pathways
  • Anecdotally reduces recovery timelines on stalled overuse injuries

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) side effects

  • Injection site irritation (occasionally with mild bluish tint from copper)
  • Temporary lightheadedness
  • Mild lethargy in first 1-2 weeks
  • Headache
  • Nausea at upper dosing range
  • Possible flushing from MSH-pathway activity (KPV)

Wolverine Blend (BPC-157 + TB-500) side effects

  • Injection site irritation or redness
  • Temporary lightheadedness or head rush
  • Mild lethargy in first 1-2 weeks
  • Headache
  • Nausea at the upper dosing range

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) dosing ranges

Inflammation + recovery loading

500 mcg KPV + 250 mcg BPC + 2 mg TB-500 + 1-2 mg GHK-Cu · KPV + BPC + GHK daily, TB-500 twice weekly · 6-8 weeks

Gut-skin axis protocol

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · Daily, with TB-500 weekly · 8-12 weeks

Maintenance

500 mcg KPV + 250 mcg BPC + 1 mg TB-500 + 1 mg GHK-Cu · KPV + BPC 3-4x weekly, others weekly · Ongoing cycles

Wolverine Blend (BPC-157 + TB-500) dosing ranges

Acute soft-tissue injury (loading)

250-500 mcg BPC + 2-5 mg TB-500 · BPC daily, TB-500 twice weekly · 4-6 weeks

Chronic tendinopathy

250 mcg BPC + 2 mg TB-500 · BPC daily, TB-500 weekly · 6-8 weeks

Maintenance after recovery

250 mcg BPC + 2 mg TB-500 · BPC 3-4x weekly, TB-500 fortnightly · 4 weeks

Full Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) guide → Full Wolverine Blend (BPC-157 + TB-500) guide →

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) vs Wolverine Blend (BPC-157 + TB-500) — common questions

What is the difference between Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) and Wolverine Blend (BPC-157 + TB-500)?

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): Four-peptide stack pairing the Glow components with KPV — anti-inflammatory, gut-supportive, and skin-regenerative in one vial. Typical dose 500 + 250 + 2000 + 1000 (KPV + BPC + TB + GHK) mcg. Wolverine Blend (BPC-157 + TB-500): The classic recovery stack — BPC-157 paired with TB-500 for accelerated tissue repair. Typical dose 250 + 2000 (BPC + TB) mcg. Both fall under the Peptide Blends category.

Can you stack Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) and Wolverine Blend (BPC-157 + TB-500)?

Stacking Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) with Wolverine Blend (BPC-157 + TB-500) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) or Wolverine Blend (BPC-157 + TB-500)?

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) is typically dosed: KPV + BPC + GHK daily, TB-500 twice weekly for Inflammation + recovery loading; Daily, with TB-500 weekly for Gut-skin axis protocol; KPV + BPC 3-4x weekly, others weekly for Maintenance. Wolverine Blend (BPC-157 + TB-500) is typically dosed: BPC daily, TB-500 twice weekly for Acute soft-tissue injury (loading); BPC daily, TB-500 weekly for Chronic tendinopathy; BPC 3-4x weekly, TB-500 fortnightly for Maintenance after recovery.

Are Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu) and Wolverine Blend (BPC-157 + TB-500) FDA approved?

Klow Blend (KPV + LL-37 / TB-500 + BPC-157 + GHK-Cu): No component FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products. Wolverine Blend (BPC-157 + TB-500): Neither component is FDA approved for human use. FDA issued a warning letter in 2024 regarding compounded BPC-157 products.

Related peptide comparisons

bpc-157 vs klow-blendghk-cu vs klow-blendglow-blend vs klow-blendklow-blend vs kpvklow-blend vs tb-500bpc-157 vs wolverine-blend

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free